Short-Term Air Pollution Exposure May ...( Gene reprogramming can occur in just ...),Health
Navigation Links
Short-Term Air Pollution Exposure May Damage DNA
Date:5/17/2009
Gene reprogramming can occur in just 3 days time
SUNDAY, May 17 (HealthDay News) -- Breathing polluted air for even a short period of time can cause some genes to undergo reprogramming, which may affect a person's risk of developing cancer and other diseases, say Italian researchers.
Comparisons of blood DNA samples from healthy workers who were exposed to high levels of airborne particulates at a foundry near Milan revealed that after only three days of exposure, changes occurred in four genes that have been linked to tumor suppression, according to research presented Sunday at the International Conference of the American Thoracic Society, in San Diego.
This finding indicates "that environmental factors need little time to cause gene reprogramming, which is potentially associated with disease outcomes," investigator Dr. Andrea Baccarelli, assistant professor of applied biotechnology at the University of Milan, said in a news release issued by the conference's sponsor.
"As several of the effects of particulate matter in foundries are similar to those found after exposure to ambient air pollution, our results open new hypotheses about how air pollutants modify human health," Baccarelli said.
The changes in the foundry workers' genes may have been caused by DNA methylation, a chemical transformation process that has been linked to gene reprogramming and has been found in the blood and tissue samples of lung cancer patients, Baccarelli noted.
"The changes in DNA methylation we observed are reversible, and some of them are currently being used as targets of cancer drugs," said the researcher, who added that it might be possible to design early interventions that could program that gene back to normal and mitigate the increased health risks of air pollutants.
"We need to evaluate how the changes in gene reprogramming we observed are related to cancer risk," Baccarelli said.
<'/>"/>
| Copyright©2009 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. Chem Rx Corporation Enters Short-Term Forbearance Agreements With Lenders
2. Decoding short-term memory with fMRI
3. Assessing the real risk of heart disease in young people with low short-term risks
4. New data show patients using avonex reported less sick leave and short-term disability costs
5. Short-term use of antipsychotics in older adults with dementia linked to serious adverse events
6. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
7. Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
8. The Westaim Corporation update on status of short-term investments
9. Short-term hemofiltration is cost-effective for severe acute pancreatitis
10. Physiotherapy has short-term benefits for patients after knee surgery
11. Air Pollution Exposure May Slow Fetal Growth
Post Your Comments:
Related Image:
 Short-Term Air Pollution Exposure May Damage DNA |
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... in the United Kingdom have determined that azithromycin, ... can be an effective treatment option for patients ... complication that occurs in the majority of patients ... leading cause of mortality after the first year ... body repeatedly rejects the transplanted lung tissue. The ...
(Date:5/22/2012)... Children born with cleft lip, cleft palate and ... appearance. , Patients can face serious airway, feeding, ... and psychological challenges, Laura Swibel Rosenthal, MD, of ... the June 2012 issue of Otolaryngologic Clinics ... patients with craniofacial syndromes is complex," Rosenthal and ...
(Date:5/22/2012)... -- Researchers at Barrow Neurological Institute at St. ... and why the public perceives some magic tricks ... in military tactics, marketing and sports. , Susana ... and Stephen Macknik, PhD, of Barrow,s Laboratory of ... into magic and illusions. Their most recent original ...
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Barrow researchers use magic for discoveries 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3[0] Patients Prefer More Invasive Form of Colon Scan: Study[0] Study shows antibiotic improves respiratory function in lung transplant patients[0] Cleft lip/palate cause much more than cosmetic problems[0] Barrow researchers use magic for discoveries[0] VCU Massey Cancer Center sees potential in novel leukemia treatment
... University have found that almost one in 10 Scottish ... of more than 2,000 students studying //in west-central Scotland ... between 13-16 demonstrated behaviors that could lead to gambling ... of 11-12 years, 6 percent of the children had ...
... his team has carried out research on a specific genetic ... one in a million births. “About 1,500 to 2,000 Americans ... says Dr. Pearson. According to him neonatal diabetes, when detected ... controlling the blood sugar levels more effectively. ,Tablets instead ...
... for a while due to its eradication, yet people could ... not been vaccinated says a recent report.// ... had spread after an unvaccinated teenager contracted the virus and ... gathering. This spurred a large outbreak in USA, which also ...
... Government of New Zealand has released a 10-year ‘action plan’ ... and addiction services. // ,It was reported that the ... and stated that the primary part of the work was ... have their needs attended to earlier by way of a ...
... an alarm clock that promises to wake its users up when ... Sleep Phase Alarm Clock checks 30 minutes before the alarm is ... or light phase of sleep, say the manufacturers Infacory Innovations, who ... recently in Munich. ,With the help of a sensor ...
... which is grown in many Indian homes, and pudina have ... University of Rajasthan.// ,"We arrived at our conclusions after ... heads the research project. ,"Our research came ... first divided into two groups and then applied with a ...
Other Medicine News:Health News:Painless Control Of Blood Sugar Levels When Detected Early 2(Date:5/23/2012)... -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today ... U.S. phase 2 clinical trial, T reatment with ... reater E fficacy T rial (TARGET-NTM), ... with non-tuberculous mycobacterial (NTM) lung disease. ... current NTM treatment recommendations, and no new drugs have ...
(Date:5/23/2012)... TriReme Medical, Inc. (TMI) today announced approval by the ... PTCA Catheter, indicated for treating the stenotic portion of ... Glider™ is the world,s only torqueable PTCA ... tip technology, Glider™ is designed to perform, even in ... an ultra short balloon length of 4mm designed for ...
(Date:5/23/2012)... Reportlinker.com announces that a new ... catalogue: Pharmaceuticals - ... http://www.reportlinker.com/p0191857/Pharmaceuticals---Global-Group-of-Eight-G8-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu ... Industry Guide is an essential resource for ... industry in each of the G8 (United ...
Breaking Medicine Technology:Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter 2Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2Pharmaceuticals - Global Group of Eight (G8) Industry Guide 3Pharmaceuticals - Global Group of Eight (G8) Industry Guide 4Pharmaceuticals - Global Group of Eight (G8) Industry Guide 5Pharmaceuticals - Global Group of Eight (G8) Industry Guide 6Pharmaceuticals - Global Group of Eight (G8) Industry Guide 7Pharmaceuticals - Global Group of Eight (G8) Industry Guide 8Pharmaceuticals - Global Group of Eight (G8) Industry Guide 9Pharmaceuticals - Global Group of Eight (G8) Industry Guide 10Pharmaceuticals - Global Group of Eight (G8) Industry Guide 11Pharmaceuticals - Global Group of Eight (G8) Industry Guide 12Pharmaceuticals - Global Group of Eight (G8) Industry Guide 13Pharmaceuticals - Global Group of Eight (G8) Industry Guide 14Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 1Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 1Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 2Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 3... Nektar,s Technology Enables First-Ever PEGylation of a Small Molecule with ... Demonstrated Therapeutic ... NKTR ) announced initial results today from a Phase ... activity in patients with refractory solid tumors. The study,also demonstrates ...
... N.J., May 16 Veridex, LLC announced today ... has commercially launched a new gene methylation test ... specificity of ,DNA,methylation, in prostate cancer, detecting the ... of DNA that occurs primarily in,cancer. Veridex is ...
Other Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 59 inch sharp bone hook with grip handle....
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
Beuse Zygomatic Arch Awl with slightly curved tip....
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |